Quick Answer
SOLIGENIX, INC. reported R&D Expense of $7.49 million for fiscal year 2025.
SOLIGENIX, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $7.49M | +43.3% |
| 2024 | $5.22M | +57.7% |
| 2023 | $3.31M | -58.3% |
| 2022 | $7.94M | -3.0% |
| 2021 | $8.19M | -16.4% |
| 2020 | $9.80M | +20.6% |
| 2019 | $8.12M | +20.3% |
| 2018 | $6.75M | +22.6% |
| 2017 | $5.51M | +28.2% |
| 2016 | $4.30M | -20.4% |
| 2015 | $5.40M | +6.2% |
| 2014 | $5.09M | +0.3% |
| 2013 | $5.07M | +94.4% |
| 2012 | $2.61M | -58.4% |
| 2011 | $6.27M | +4.8% |
| 2010 | $5.99M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.58M | +63.5% | -5.6% |
| June 30, 2025 | $1.68M | +234.6% | -13.6% |
| March 31, 2025 | $1.94M | +77.3% | +100.4% |
| September 30, 2024 | $968.7K | +17.3% | +93.3% |
| June 30, 2024 | $501.2K | -34.3% | -54.2% |
| March 31, 2024 | $1.10M | +15.7% | +32.6% |
| September 30, 2023 | $826.0K | -53.9% | +8.3% |
| June 30, 2023 | $762.7K | -62.8% | -19.4% |
- SOLIGENIX, INC. showed an increase of +43.3% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, SOLIGENIX, INC.’s r&d expense has grown by 25.0% (from $5.99 million to $7.49 million).
- The most recent figure is from SOLIGENIX, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: